Incretin therapies in the management of patients with type 2 diabetes mellitus and renal impairment.

Hospital practice (1995)

Volumn 40, Issue 2, 2012, Pages 7-21

  Dejager, Sylvie ^a   Schweizer, Anja ^b  

^a NOVARTIS PHARMA K K   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; DRUG DERIVATIVE; GLUCAGON LIKE PEPTIDE 1; INCRETIN;

CLINICAL TRIAL (TOPIC); DIABETIC NEPHROPATHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; REVIEW;

ADMINISTRATION, ORAL; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INCRETINS; INJECTIONS, INTRAVENOUS;

EID: 84863885880     PISSN: 21548331     EISSN: None     Source Type: Journal    
DOI: 10.3810/hp.2012.04.965     Document Type: Review

References (0)